What is Irobot's earnings per share (EPS)?

Irobot (IRBTQ) reported diluted earnings per share of -$4.92 for fiscal year 2024. This represents a 55.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Irobot (IRBTQ) Financials

IRBTQ

Trailing 12 months to September 27, 2025

Revenue $547.0M -33.1% YoY

Net Income -$208.7M -58.1% YoY

EPS (Diluted) -$6.72 -46.1% YoY

Free Cash Flow -$106.9M -234.0% YoY

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Sep 27, 2025 Reported Nov 6, 2025 Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2025, filed Nov 6, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the IRBTQ SEC filings page.

Irobot (IRBTQ) reported $547.0M in revenue over the twelve months to Sep 27, 2025, down 33.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI IRBTQ FY2024 2026-08-30

Shrinking sales are revealing a harsher mechanic: margin compression is weakening earnings while leverage increasingly pressures a thinner equity base.

Revenue contracted 52.3% from FY2020 to FY2024, while gross margin fell to 20.9%. That pairing indicates the business is not simply smaller; each remaining sales dollar is producing less room to absorb operating costs.

In FY2024, operating cash flow was -$33.2M and free cash flow was -$33.3M. With capital expenditures of $118K, the near-match means cash consumption came mainly from the operating model, not expansion spending.

Debt-to-equity rose from 0.5x in FY2020 to 7.4x in FY2024 as equity deteriorated. Equity fell to $61.2M and the current ratio to 1.3x, leaving a thinner balance-sheet cushion against continued operating losses.

Financial Health Signals

Financial health score not available

Irobot does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

3/8

Irobot passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

N/A

Irobot reported a net loss of $145.5M while operations used $33.2M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Irobot reported an operating loss of $103.0M against $21.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$145.8M

YoY-24.6%

QoQ+14.3%

5Y CAGR-5.4%

10Y CAGR+0.2%

Irobot generated $145.8M in revenue in Q3 2025. This represents a decrease of 24.6% from the same quarter a year earlier. Against the prior quarter it is up 14.3%.

EBITDA

-$16.1M

YoY-223.6%

QoQ+53.8%

Irobot's EBITDA was -$16.1M in Q3 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 223.6% from the same quarter a year earlier. Against the prior quarter it is up 53.8%.

Net Income

-$21.5M

YoY-237.9%

QoQ+5.6%

Irobot reported -$21.5M in net income in Q3 2025. This represents a decrease of 237.9% from the same quarter a year earlier. Against the prior quarter it is up 5.6%.

EPS (Diluted)

-$0.62

YoY-195.2%

QoQ+8.8%

Irobot earned -$0.62 per diluted share (EPS) in Q3 2025. This represents a decrease of 195.2% from the same quarter a year earlier. Against the prior quarter it is up 8.8%.

Cash & Balance Sheet

Free Cash Flow

-$47.6M

YoY-364.6%

QoQ-57.8%

Irobot recorded an outflow of $47.6M in free cash flow in Q3 2025, representing a cash shortfall after capex. This represents a decrease of 364.6% from the same quarter a year earlier. Against the prior quarter it is down 57.8%.

Cash & Debt

$24.8M

YoY-75.0%

QoQ-38.8%

5Y CAGR-36.9%

10Y CAGR-16.4%

Irobot held $24.8M in cash as of Q3 2025; long-term debt is not reported for that period.

Shares Outstanding

32M

YoY+4.1%

QoQ+1.5%

5Y CAGR+2.7%

10Y CAGR+0.7%

Irobot had 32M shares outstanding in Q3 2025. This represents an increase of 4.1% from the same quarter a year earlier. Against the prior quarter it is up 1.5%.

Dividends Per Share

Not reported for Q3 2025.

Margins & Returns

Gross Margin

31.0%

YoY-1.2pp

QoQ+1.0pp

5Y change-9.5pp

10Y change-16.3pp

Irobot's gross margin was 31.0% in Q3 2025, indicating the percentage of revenue retained after direct costs. This is down 1.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.0 percentage points.

Operating Margin

-12.1%

YoY-15.9pp

QoQ+16.7pp

Irobot's operating margin was -12.1% in Q3 2025, reflecting core business profitability. This is down 15.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 16.7 percentage points.

Net Margin

-14.8%

YoY-11.5pp

QoQ+3.1pp

5Y change-5.3pp

10Y change-24.9pp

Irobot's net profit margin was -14.8% in Q3 2025, showing the share of revenue converted to profit. This is down 11.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.1 percentage points.

Return on Equity

Not reported for Q3 2025.

Capital Allocation

R&D Spending

$13.1M

YoY-33.3%

QoQ-4.9%

Irobot invested $13.1M in research and development in Q3 2025. This represents a decrease of 33.3% from the same quarter a year earlier. Against the prior quarter it is down 4.9%.

Capital Expenditures

Irobot reported no capital expenditure in Q3 2025.

Share Buybacks

Not reported for Q3 2025.

IRBTQ Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IRBTQ quarterly income statement

Metric	TTM	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Revenue	$547.0M	$681.8M-23.4%	$890.6M-24.7%	$1.2B-24.4%	$1.6B+9.4%	$1.4B+17.8%	$1.2B+11.1%	$1.1B+23.6%	$883.9M+33.8%	$660.6M+7.1%	$616.8M+10.8%	$556.8M+14.2%	$487.4M+11.7%	$436.2M-6.3%	$465.5M+16.1%	$401.0M
Cost of Revenue	$426.7M	$539.5M-22.3%	$694.2M-16.7%	$833.3M-17.9%	$1.0B+33.5%	$760.2M+13.4%	$670.1M+24.7%	$537.2M+19.2%	$450.8M+32.1%	$341.3M+4.1%	$327.9M+9.7%	$298.8M+12.2%	$266.2M+10.1%	$241.9M-6.2%	$257.8M+0.9%	$255.5M
Gross Profit	$120.3M	$142.4M-27.5%	$196.4M-43.9%	$350.1M-36.4%	$550.3M-17.9%	$670.2M+23.2%	$543.9M-2.1%	$555.4M+28.2%	$433.2M+35.7%	$319.3M+10.5%	$288.9M+12.0%	$258.1M+16.7%	$221.2M+13.8%	$194.3M-6.4%	$207.7M+42.8%	$145.4M
R&D Expenses	$58.1M	$93.3M-35.0%	$143.5M-13.1%	$165.2M+2.4%	$161.3M+3.0%	$156.7M+10.6%	$141.6M+0.7%	$140.6M+24.3%	$113.1M+41.8%	$79.8M+4.9%	$76.1M+9.6%	$69.4M+9.0%	$63.6M+11.5%	$57.1M-5.0%	$60.1M+142.3%	$24.8M
SG&A Expenses	N/A	N/A	$109.1M-7.6%	$118.1M+19.1%	$99.2M-1.6%	$100.8M+21.3%	$83.1M-14.8%	$97.5M+15.0%	$84.8M+26.8%	$66.8M+24.8%	$53.5M+8.3%	$49.4M-7.3%	$53.4M+16.8%	$45.7M+4.4%	$43.8M+19.5%	$36.6M
Operating Income	-$161.2M	-$103.0M+61.0%	-$264.1M-9.9%	-$240.4M-21753.0%	-$1.1M-100.8%	$146.3M+68.9%	$86.6M-18.1%	$105.8M+45.6%	$72.7M+26.3%	$57.6M-5.0%	$60.6M+14.1%	$53.1M+62.8%	$32.6M+29.6%	$25.2M-52.8%	$53.3M+59.3%	$33.5M
EBITDA	N/A	-$81.3M+64.9%	-$231.3M-20.1%	-$192.5M-697.7%	$32.2M-82.2%	$181.1M+46.3%	$123.8M-13.1%	$142.4M+45.0%	$98.2M+38.0%	$71.2M-6.3%	$75.9M+14.7%	$66.2M+47.7%	$44.8M+21.6%	$36.8M-42.1%	$63.6M+55.2%	$41.0M
Interest Expense	$16.9M	$21.5M+102.8%	$10.6M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$1.5M	$378K-96.8%	$11.7M-52.6%	$24.6M+1268.7%	-$2.1M-105.2%	$40.8M+201.8%	$13.5M-34.4%	$20.6M-18.8%	$25.4M+30.8%	$19.4M+3.1%	$18.8M+29.0%	$14.6M+205.9%	$4.8M-42.6%	$8.3M-37.8%	$13.3M+57.8%	$8.5M
Net Income	-$208.7M	-$145.5M+52.2%	-$304.7M-6.4%	-$286.3M-1042.1%	$30.4M-79.3%	$147.1M+72.4%	$85.3M-3.1%	$88.0M+72.7%	$51.0M+21.5%	$41.9M-5.0%	$44.1M+16.7%	$37.8M+36.8%	$27.6M+59.8%	$17.3M-57.0%	$40.2M+57.5%	$25.5M
EPS (Basic)	N/A	-$4.92+55.3%	-$11.01-4.7%	-$10.52-1056.4%	$1.10-79.0%	$5.23+72.0%	$3.04-4.4%	$3.18+71.9%	$1.85+22.5%	$1.51+1.3%	$1.49+16.4%	$1.28+32.0%	$0.97+54.0%	$0.63-58.0%	$1.50+50.0%	$1.00
EPS (Diluted)	-$6.72	-$4.92+55.3%	-$11.01-4.7%	-$10.52-1074.1%	$1.08-79.0%	$5.14+73.1%	$2.97-3.3%	$3.07+73.4%	$1.77+19.6%	$1.48+0.7%	$1.47+17.6%	$1.25+33.0%	$0.94+54.1%	$0.61-57.6%	$1.44+50.0%	$0.96
Diluted Shares (Avg)	N/A	30M+7.0%	28M+1.7%	27M-3.4%	28M-1.6%	29M-0.4%	29M+0.3%	29M-0.4%	29M+1.6%	28M-6.0%	30M-0.3%	30M+2.9%	29M+3.7%	28M+1.4%	28M+5.5%	26M

Metric	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-Q	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K
Revenue	$145.8M-24.6%	$127.6M-23.3%	$101.6M-32.3%	$172.0M-44.1%	$193.4M+3.9%	$166.4M+3.8%	$150.0M	$307.5M+10.6%
Cost of Revenue	$100.6M-23.3%	$89.3M-35.7%	$81.3M-28.7%	$155.6M-37.6%	$131.1M-5.2%	$138.9M+12.4%	$113.9M	$249.4M+23.6%
Gross Profit	$45.3M-27.5%	$38.3M+39.4%	$20.3M-43.7%	$16.4M-71.8%	$62.4M+30.0%	$27.5M-25.2%	$36.1M	$58.1M-23.9%
R&D Expenses	$13.1M-33.3%	$13.8M-40.7%	$14.7M-56.7%	$16.5M-38.6%	$19.6M-47.4%	$23.2M-43.7%	$33.9M	$26.9M-34.9%
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$18.9M-40.0%
Operating Income	-$17.7M-343.5%	-$36.7M+39.9%	-$45.8M-484.5%	-$61.0M-16.9%	$7.3M+112.2%	-$61.1M+24.9%	$11.9M	-$52.2M+23.6%
EBITDA	-$16.1M-223.6%	-$35.0M+37.3%	-$43.1M-343.5%	-$56.3M-37.9%	$13.1M+124.6%	-$55.8M+24.4%	$17.7M	-$40.8M+16.7%
Interest Expense	$1.6M-70.4%	$5.1M-5.6%	$5.0M-9.1%	$5.2M	$5.4M	$5.4M	$5.5M	N/A
Income Tax	$3.1M+191.1%	-$523K-171.7%	$457K+323.1%	-$1.5M-123.3%	$1.1M+80.6%	$729K+157.8%	$108K	$6.6M-88.8%
Net Income	-$21.5M-237.9%	-$22.8M+67.7%	-$87.3M-1114.0%	-$77.1M-21.3%	-$6.4M+92.0%	-$70.6M+12.9%	$8.6M	-$63.6M+50.5%
EPS (Basic)	-$0.62-195.2%	-$0.68+71.8%	-$2.84-1016.1%	-$2.58-13.2%	-$0.21+92.7%	-$2.41+18.3%	$0.31	-$2.28+51.6%
EPS (Diluted)	-$0.62-195.2%	-$0.68+71.8%	-$2.84-1046.7%	-$2.58-13.2%	-$0.21+92.7%	-$2.41+18.3%	$0.30	-$2.28+51.6%
Diluted Shares (Avg)	35M+14.9%	33M+14.0%	31M+8.7%	N/A	30M+9.4%	29M+6.7%	28M	N/A

IRBTQ Balance Sheet

IRBTQ quarterly balance sheet

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Total Assets	$516.1M-29.7%	$733.7M-12.2%	$835.4M-29.5%	$1.2B-0.4%	$1.2B+29.2%	$920.8M+20.1%	$767.0M+10.9%	$691.5M+36.1%	$507.9M-2.7%	$521.7M+5.8%	$493.2M+18.5%	$416.3M+17.5%	$354.3M+6.7%	$332.2M+30.6%	$254.3M
Current Assets	$288.5M-38.0%	$465.5M-11.9%	$528.3M-33.1%	$789.5M-10.4%	$881.2M+48.3%	$594.2M+15.5%	$514.4M+18.3%	$434.7M+13.3%	$383.7M-1.5%	$389.3M+3.9%	$374.9M+24.7%	$300.7M+28.0%	$234.9M-17.3%	$284.2M+37.6%	$206.6M
Cash & Equivalents	$134.3M-27.5%	$185.1M+57.0%	$117.9M-41.5%	$201.5M-53.4%	$432.6M+80.7%	$239.4M+83.6%	$130.4M+1.4%	$128.6M-40.0%	$214.5M+19.2%	$179.9M-3.2%	$186.0M+12.4%	$165.4M+30.5%	$126.8M-23.8%	$166.3M+53.4%	$108.4M
Short-Term Investments	$0	$0	$0-100.0%	$33.0M-35.3%	$51.1M+199.9%	$17.0M-46.1%	$31.6M-15.1%	$37.2M-6.8%	$39.9M+20.5%	$33.1M-8.4%	$36.2M+64.7%	$22.0M+76.6%	$12.4M-30.2%	$17.8M+27.9%	$13.9M
Inventory	$76.0M-50.1%	$152.5M-46.5%	$285.3M-14.4%	$333.3M+83.4%	$181.8M+15.5%	$157.3M-4.4%	$164.6M+54.0%	$106.9M+111.4%	$50.6M-18.0%	$61.7M+28.9%	$47.9M+3.8%	$46.1M+24.7%	$37.0M+18.9%	$31.1M+14.5%	$27.2M
Accounts Receivable	$49.9M-37.2%	$79.4M+20.2%	$66.0M-58.9%	$160.6M-5.8%	$170.5M+16.7%	$146.2M-9.9%	$162.2M+14.5%	$141.6M+93.9%	$73.0M-30.2%	$104.7M+47.3%	$71.1M+80.6%	$39.3M+33.8%	$29.4M-32.1%	$43.3M+27.3%	$34.1M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$167.3M-4.5%	$175.1M+4.4%	$167.7M-3.2%	$173.3M+37.7%	$125.9M+6.0%	$118.7M-0.1%	$118.9M-2.1%	$121.4M+195.9%	$41.0M-15.8%	$48.8M0.0%	$48.8M0.0%	$48.8M-0.4%	$49.0M+518.8%	$7.9M	N/A
Total Liabilities	$454.9M-15.3%	$537.2M+49.3%	$359.7M-23.1%	$467.7M+21.4%	$385.3M+43.4%	$268.7M+16.0%	$231.6M+4.7%	$221.2M+85.9%	$119.0M+14.0%	$104.3M+1.5%	$102.8M+20.0%	$85.6M+9.1%	$78.5M-12.1%	$89.3M+12.4%	$79.4M
Current Liabilities	$218.2M-24.0%	$287.1M-3.1%	$296.2M-25.1%	$395.7M+28.6%	$307.6M+51.9%	$202.5M-5.3%	$213.8M+8.1%	$197.7M+75.5%	$112.6M+16.6%	$96.6M-2.4%	$99.0M+22.4%	$80.9M+8.9%	$74.3M-12.6%	$85.0M+12.1%	$75.8M
Non-Current Liabilities	$236.7M-5.4%	$250.1M+293.5%	$63.5M-11.8%	$72.0M-7.3%	$77.7M+17.4%	$66.2M+270.1%	$17.9M-23.8%	$23.5M+271.4%	$6.3M-18.0%	$7.7M+106.3%	$3.7M-21.1%	$4.7M+12.2%	$4.2M-0.9%	$4.3M+18.7%	$3.6M
Total Equity	$61.2M-68.8%	$196.5M-58.7%	$475.7M-33.6%	$716.7M-10.9%	$804.4M+23.4%	$652.1M+21.8%	$535.3M+13.8%	$470.3M+20.9%	$389.0M-6.8%	$417.4M+6.9%	$390.4M+18.1%	$330.7M+19.9%	$275.8M+13.5%	$243.0M+38.9%	$174.9M
Retained Earnings	-$250.8M-138.2%	-$105.3M-152.8%	$199.4M-58.9%	$485.7M-19.0%	$599.4M+32.5%	$452.3M+23.2%	$367.0M+32.0%	$278.0M+22.5%	$226.9M+22.7%	$185.0M+31.3%	$140.9M+36.7%	$103.1M+36.6%	$75.4M+29.8%	$58.1M+223.9%	$17.9M

Metric	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-Q	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K
Total Assets	$481.6M-28.1%	$480.3M-18.0%	$461.5M-26.3%	$516.1M-29.7%	$669.9M-19.4%	$585.9M-11.8%	$626.1M	$733.7M-29.3%
Current Assets	$248.5M-41.4%	$244.8M-28.0%	$234.3M-37.0%	$288.5M-38.0%	$423.8M-23.9%	$340.1M-6.6%	$371.9M	$465.5M-35.9%
Cash & Equivalents	$24.8M-75.0%	$40.6M-62.6%	$69.9M-40.9%	$134.3M-27.5%	$99.4M-47.6%	$108.5M+126.5%	$118.4M	$185.1M+106.6%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$140.9M-5.5%	$88.2M-13.0%	$69.0M-48.3%	$76.0M-50.1%	$149.2M-39.0%	$101.4M-55.9%	$133.3M	$152.5M-63.6%
Accounts Receivable	$56.8M-43.9%	$56.1M-17.7%	$30.8M-21.7%	$49.9M-37.2%	$101.3M+37.9%	$68.1M+129.8%	$39.3M	$79.4M-40.3%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$182.4M+3.7%	$182.4M+7.7%	$171.5M+1.1%	$167.3M-4.5%	$175.9M+5.0%	$169.4M-0.1%	$169.7M	$175.1M+9.8%
Total Liabilities	$508.5M-2.2%	$488.0M+11.7%	$462.3M+9.5%	$454.9M-15.3%	$519.8M-10.2%	$436.9M+62.3%	$422.1M	$537.2M+12.7%
Current Liabilities	$480.9M+64.3%	$456.6M+106.0%	$427.9M+106.4%	$218.2M-24.0%	$292.6M-10.1%	$221.6M+3.6%	$207.4M	$287.1M-31.7%
Non-Current Liabilities	$27.6M-87.9%	$31.4M-85.4%	$34.4M-84.0%	$236.7M-5.4%	$227.1M-10.3%	$215.2M+290.0%	$214.7M	$250.1M+345.7%
Total Equity	-$26.9M-117.9%	-$7.7M-105.2%	-$793K-100.4%	$61.2M-68.8%	$150.2M-40.6%	$149.1M-62.3%	$204.1M	$196.5M-65.0%
Retained Earnings	-$382.4M-120.2%	-$360.9M-115.7%	-$338.1M-249.7%	-$250.8M-138.2%	-$173.7M-316.5%	-$167.3M-241.4%	-$96.7M	-$105.3M-137.1%

Not reported in any period shown, so not listed: Long-Term Debt.

IRBTQ Cash Flow Statement

IRBTQ quarterly cash flow statement

Metric	TTM	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Operating Cash Flow	-$106.9M	-$33.2M+71.1%	-$114.8M-27.5%	-$90.0M-181.6%	-$32.0M-113.8%	$232.0M+78.4%	$130.1M+81.4%	$71.7M-6.1%	$76.3M-34.5%	$116.4M+335.8%	$26.7M-34.2%	$40.6M-3.1%	$41.9M+10.6%	$37.9M-32.1%	$55.7M+13.4%	$49.2M
Depreciation & Amortization	N/A	$21.7M-33.9%	$32.8M-31.5%	$47.9M+43.7%	$33.3M-4.2%	$34.8M-6.5%	$37.2M+1.6%	$36.6M+43.4%	$25.5M+87.4%	$13.6M-11.1%	$15.3M+17.3%	$13.0M+7.2%	$12.2M+4.3%	$11.7M+13.2%	$10.3M+36.7%	$7.5M
Stock-Based Compensation	N/A	$24.5M-32.1%	$36.1M+13.0%	$31.9M+47.1%	$21.7M-27.6%	$30.0M+26.2%	$23.7M-8.0%	$25.8M+30.6%	$19.8M+23.5%	$16.0M+12.8%	$14.2M+2.9%	$13.8M+2.8%	$13.4M+22.1%	$11.0M+25.0%	$8.8M+7.6%	$8.2M
Capital Expenditures	$0	$118K-95.9%	$2.9M-76.8%	$12.3M-58.8%	$29.9M-5.3%	$31.6M-10.6%	$35.3M+9.0%	$32.4M+38.7%	$23.4M+116.1%	$10.8M+15.4%	$9.4M-32.0%	$13.8M+101.7%	$6.8M+0.9%	$6.8M-48.0%	$13.0M+3.3%	$12.6M
Free Cash Flow	-$106.9M	-$33.3M+71.7%	-$117.7M-15.0%	-$102.3M-65.3%	-$61.9M-130.9%	$200.4M+111.6%	$94.7M+141.2%	$39.3M-25.8%	$52.9M-49.9%	$105.6M+509.0%	$17.3M-35.4%	$26.8M-23.5%	$35.1M+12.8%	$31.1M-27.2%	$42.7M+16.9%	$36.6M
Investing Cash Flow	$500K	-$254K+91.8%	-$3.1M-237.7%	$2.2M+104.7%	-$48.1M-116.3%	-$22.2M-6.3%	-$20.9M+20.6%	-$26.4M+84.5%	-$169.9M-4155.4%	$4.2M+309.8%	-$2.0M+93.1%	-$28.7M-59.0%	-$18.1M+78.1%	-$82.4M-379.0%	-$17.2M+20.2%	-$21.6M
Financing Cash Flow	-$4.5M	-$16.7M-109.0%	$185.4M+6196.5%	$2.9M+102.0%	-$148.4M-598.2%	-$21.3M-16254.6%	-$130K+99.7%	-$43.2M-668.7%	$7.6M+108.8%	-$86.0M-179.6%	-$30.8M-453.9%	$8.7M-41.4%	$14.8M+197.2%	$5.0M-74.3%	$19.4M+117.2%	$8.9M
Share Buybacks	N/A	N/A	$0	$0-100.0%	$150.0M+500.0%	$25.0M	$0-100.0%	$50.0M	$0-100.0%	$97.0M+159.5%	$37.4M+2128.4%	$1.7M	$0	$0	N/A	N/A

Metric	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-Q	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K
Operating Cash Flow	-$47.6M-364.6%	-$30.2M-39.2%	-$26.5M-1941.3%	-$2.7M-137.5%	-$10.2M+81.6%	-$21.7M+77.1%	$1.4M	-$1.2M+95.6%
Depreciation & Amortization	$1.5M-73.5%	$1.8M-66.8%	$2.6M-54.9%	$4.8M-58.4%	$5.8M-11.2%	$5.3M-29.7%	$5.8M	$11.4M-41.0%
Stock-Based Compensation	N/A	N/A	$5.3M-33.1%	N/A	N/A	N/A	$7.9M	N/A
Capital Expenditures	$0	$0	$0-100.0%	$0-100.0%	$0-100.0%	$0-100.0%	$118K	-$270K-93.3%
Free Cash Flow	-$47.6M-364.6%	-$30.2M-39.2%	-$26.5M-2106.1%	-$2.7M-92.6%	-$10.2M+81.8%	-$21.7M+77.4%	$1.3M	-$1.4M+95.3%
Investing Cash Flow	$594K+6040.0%	-$6K+87.0%	-$8K+93.2%	-$80K-132.0%	-$10K+98.5%	-$46K+97.0%	-$118K	$250K+106.7%
Financing Cash Flow	-$114K-108.5%	-$4.2M-134.8%	-$84K+99.7%	-$132K+85.0%	$1.3M-99.3%	$12.0M-52.8%	-$29.9M	-$878K-101.6%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

IRBTQ Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IRBTQ quarterly financial ratios

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Gross Margin	20.9%-1.2pp	22.1%-7.5pp	29.6%-5.6pp	35.2%-11.7pp	46.9%+2.1pp	44.8%-6.0pp	50.8%+1.8pp	49.0%+0.7pp	48.3%+1.5pp	46.8%+0.5pp	46.3%+1.0pp	45.4%+0.8pp	44.5%-0.1pp	44.6%+8.3pp	36.3%
Operating Margin	-15.1%+14.5pp	-29.6%-9.3pp	-20.3%-20.2pp	-0.1%-10.3pp	10.2%+3.1pp	7.1%-2.6pp	9.7%+1.5pp	8.2%-0.5pp	8.7%-1.1pp	9.8%+0.3pp	9.5%+2.8pp	6.7%+0.9pp	5.8%-5.7pp	11.5%+3.1pp	8.3%
Net Margin	-21.3%+12.9pp	-34.2%-10.0pp	-24.2%-26.1pp	1.9%-8.3pp	10.3%+3.3pp	7.0%-1.0pp	8.1%+2.3pp	5.8%-0.6pp	6.3%-0.8pp	7.1%+0.4pp	6.8%+1.1pp	5.7%+1.7pp	4.0%-4.7pp	8.6%+2.3pp	6.4%
Return on Equity	-237.6%-82.5pp	-155.1%-94.9pp	-60.2%-64.4pp	4.2%-14.0pp	18.3%+5.2pp	13.1%-3.4pp	16.4%+5.6pp	10.8%+0.1pp	10.8%+0.2pp	10.6%+0.9pp	9.7%+1.3pp	8.4%+2.1pp	6.3%-10.3pp	16.5%+1.9pp	14.6%
Return on Assets	-28.2%+13.3pp	-41.5%-7.3pp	-34.3%-36.8pp	2.6%-9.8pp	12.4%+3.1pp	9.3%-2.2pp	11.5%+4.1pp	7.4%-0.9pp	8.3%-0.2pp	8.5%+0.8pp	7.7%+1.0pp	6.6%+1.8pp	4.9%-7.2pp	12.1%+2.1pp	10.0%
Current Ratio	1.32-0.3x	1.62-0.2x	1.78-0.2x	2.00-0.9x	2.87-0.1x	2.93+0.5x	2.41+0.2x	2.20-1.2x	3.41-0.6x	4.03+0.2x	3.78+0.1x	3.72+0.6x	3.16-0.2x	3.34+0.6x	2.72
Debt-to-Equity	7.43+4.7x	2.73+2.0x	0.76+0.1x	0.65+0.2x	0.48+0.1x	0.410.0x	0.430.0x	0.47+0.2x	0.31+0.1x	0.250.0x	0.260.0x	0.260.0x	0.28-0.1x	0.37-0.1x	0.45
Asset Turnover	1.32+0.1x	1.21-0.2x	1.42+0.1x	1.32+0.1x	1.20-0.1x	1.32-0.1x	1.42+0.1x	1.280.0x	1.30+0.1x	1.18+0.1x	1.130.0x	1.17-0.1x	1.23-0.2x	1.40-0.2x	1.58
FCF Margin	-4.9%+8.3pp	-13.2%-4.6pp	-8.6%-4.7pp	-4.0%-18.0pp	14.0%+6.2pp	7.8%+4.2pp	3.6%-2.4pp	6.0%-10.0pp	16.0%+13.2pp	2.8%-2.0pp	4.8%-2.4pp	7.2%+0.1pp	7.1%-2.1pp	9.2%+0.1pp	9.1%

Metric	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-Q	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K
Gross Margin	31.0%-1.2pp	30.0%+13.5pp	20.0%-4.1pp	9.5%-9.4pp	32.3%+6.5pp	16.5%-6.4pp	24.1%	18.9%-8.6pp
Operating Margin	-12.1%-15.9pp	-28.8%+7.9pp	-45.0%-53.0pp	-35.5%-18.5pp	3.8%+35.7pp	-36.7%+14.0pp	7.9%	-17.0%+7.6pp
Net Margin	-14.8%-11.5pp	-17.9%+24.6pp	-85.9%-91.7pp	-44.8%-24.1pp	-3.3%+39.3pp	-42.5%+8.1pp	5.7%	-20.7%+25.5pp
Return on Equity	N/A	N/A	N/A	-125.9%-93.5pp	-4.2%+27.1pp	-47.4%-26.9pp	4.2%	-32.4%-9.5pp
Return on Assets	-4.5%-3.5pp	-4.8%+7.3pp	-18.9%-20.3pp	-14.9%-6.3pp	-0.9%+8.6pp	-12.1%+0.1pp	1.4%	-8.7%+3.7pp
Current Ratio	0.52-0.9x	0.54-1.0x	0.55-1.2x	1.32-0.3x	1.45-0.3x	1.53-0.2x	1.79	1.62-0.1x
Debt-to-Equity	N/A	N/A	N/A	7.43+4.7x	3.46+1.2x	2.93+2.2x	2.07	2.73+1.9x
Asset Turnover	0.300.0x	0.270.0x	0.220.0x	0.33-0.1x	0.29+0.1x	0.280.0x	0.24	0.42+0.2x
FCF Margin	-32.6%-27.3pp	-23.6%-10.6pp	-26.1%-26.9pp	-1.6%-1.1pp	-5.3%+24.9pp	-13.0%+46.8pp	0.9%	-0.5%+10.4pp

Where Irobot Ranks

Frequently Asked Questions

What is Irobot's annual revenue?

Irobot (IRBTQ) reported $681.8M in total revenue for fiscal year 2024. This represents a -23.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Irobot's revenue growing?

Irobot (IRBTQ) revenue declined by 23.4% year-over-year, from $890.6M to $681.8M in fiscal year 2024.

Is Irobot profitable?

No, Irobot (IRBTQ) reported a net income of -$145.5M in fiscal year 2024, with a net profit margin of -21.3%.

What is Irobot's EBITDA?

Irobot (IRBTQ) had EBITDA of -$81.3M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is Irobot's gross margin?

Irobot (IRBTQ) had a gross margin of 20.9% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Irobot's operating margin?

Irobot (IRBTQ) had an operating margin of -15.1% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Irobot's net profit margin?

Irobot (IRBTQ) had a net profit margin of -21.3% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Irobot's return on equity (ROE)?

Irobot (IRBTQ) has a return on equity of -237.6% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Irobot's free cash flow?

Irobot (IRBTQ) recorded an outflow of $33.3M in free cash flow during fiscal year 2024. This represents a 71.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Irobot's operating cash flow?

Irobot (IRBTQ) recorded an outflow of $33.2M in operating cash flow during fiscal year 2024, representing cash used by core business activities.

What are Irobot's total assets?

Irobot (IRBTQ) had $516.1M in total assets as of fiscal year 2024, including both current and long-term assets.

What are Irobot's capital expenditures?

Irobot (IRBTQ) invested $118K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How much does Irobot spend on research and development?

Irobot (IRBTQ) invested $93.3M in research and development during fiscal year 2024.

How many shares does Irobot have outstanding?

Irobot (IRBTQ) had 31M shares outstanding as of fiscal year 2024.

What is Irobot's current ratio?

Irobot (IRBTQ) had a current ratio of 1.32 as of fiscal year 2024, which is considered adequate.

What is Irobot's debt-to-equity ratio?

Irobot (IRBTQ) had a debt-to-equity ratio of 7.43 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Irobot's return on assets (ROA)?

Irobot (IRBTQ) had a return on assets of -28.2% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Irobot's Piotroski F-Score?

Irobot (IRBTQ) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Irobot's earnings high quality?

Irobot (IRBTQ) reported a net loss of $145.5M while operations used $33.2M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Irobot cover its interest payments?

Irobot (IRBTQ) reported an operating loss of $103.0M against $21.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.